According to a new study, inflammation from bacterial infections is linked to pre-term births and deaths.
Researchers from Case Western Reserve University's School of Dental Medicine and the Case School of Medicine have found that receptors responding to the presence of dead or living bacteria in the placentas of mice can be blocked, the number of pre-term deaths will decline by nearly half.
"New findings from the mouse study holds potential to develop ways to curb the emotional and economic toll on families that lose babies to pre-term labour and foetal death," said Yiping Han, a member of from the department of periodontics.
In a prior mouse study at Case Western Reserve, the investigators noted that inflammation closely paralleled localization of bacteria. In the present study, the researchers found that mice deficient in TLR4 lacked the necro-inflammatory response to bacteria and produced healthy pups. This discovery led Han and her colleagues to attempt to block the inflammatory process by using synthetic TLR4 antagonist that prevented the receptor from sensing the bacteria.
Fusobacterium nucleatum, a common oral pathogen also found in the amniotic fluid of pre-term babies, was used as the model organism for the study. Around day 16 of the gestation period for the mice (the equivalent of the third trimester for humans), F. nucleatum was injected into three groups of mice-one that had TLR4 receptors, a group of TLR4-deficient mice and a group that had TLR4 receptors but were given a synthetic compound to block the receptor's inflammatory response. Within eighteen hours, inflammation was present in the TLR4 mice.
"F. nucleatum colonization in the mouse placenta was accompanied by inflammation, similar to intrauterine infection in humans, suggesting placental inflammatory response as an important factor in the pathogenesis of bacterial-inducted pre-term birth," The researchers wrote.
The researchers found that the TLR4-deficient mice gave birth to healthy pups. The TLR4 group that was not given the synthetic compound to block TLR4 from reacting to bacteria had a 50pct increase in foetal death over the mice that had TLR4 but were given the compound to block the inflammatory response. In the TLR4-deficient mice, there were very few foetal deaths.
Han said the synthetic TLR4 antagonist appears to be safe for mice mothers and their pups.
The researchers said they hope to find ways to prevent pre-term labour that complicates 12 pct of all live deliveries and results in 70 pct of neonatal deaths. Pre-term births affect nearly half a million babies in the U.S. each year and cost billions of dollars in health costs annually. Han added that the 30 pct increase in pre-term births in recent decades makes it especially important to investigate novel ways of reversing this trend.
The study is published in the Journal of Immunology.